Last reviewed · How we verify
Counseling +CHC — Competitive Intelligence Brief
phase 3
Psychiatry / Substance Use Disorder
Small molecule
Live · refreshed every 30 min
Target snapshot
Counseling +CHC (Counseling +CHC) — Friends Research Institute, Inc.. Counseling combined with contingency management (CHC) uses behavioral reinforcement and motivational interviewing to modify substance use behaviors.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Counseling +CHC TARGET | Counseling +CHC | Friends Research Institute, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Counseling +CHC CI watch — RSS
- Counseling +CHC CI watch — Atom
- Counseling +CHC CI watch — JSON
- Counseling +CHC alone — RSS
Cite this brief
Drug Landscape (2026). Counseling +CHC — Competitive Intelligence Brief. https://druglandscape.com/ci/counseling-chc. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing